| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | William G. Haynes | Q47151017 |
| Marcelo Correia | Q60646611 | ||
| P2093 | author name string | Marcelo L G Correia | |
| P2860 | cites work | Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness | Q22306395 |
| Role of endothelin in cardiovascular disease | Q28216230 | ||
| Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in man | Q28346095 | ||
| Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries | Q28573239 | ||
| Increased ambulatory pulse pressure is a strong risk factor for coronary endothelial vasomotor dysfunction | Q31165759 | ||
| Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans | Q31918328 | ||
| Impact of aortic stiffness on survival in end-stage renal disease | Q33861423 | ||
| Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients | Q33862661 | ||
| Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A | Q33989952 | ||
| Pulse pressure--a review of mechanisms and clinical relevance | Q34192259 | ||
| Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms | Q34389764 | ||
| Pulse pressure, endothelium function, and arterial stiffness in spontaneously hypertensive rats | Q34467467 | ||
| Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study | Q34494252 | ||
| Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene | Q34693858 | ||
| Noninvasive assessment of arterial stiffness and risk of atherosclerotic events | Q35077355 | ||
| Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K+ channels: relevance to varicose vein formation | Q35630450 | ||
| Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population | Q73951404 | ||
| Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease | Q74756562 | ||
| Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects | Q77310325 | ||
| Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans | Q78253221 | ||
| Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index | Q79125172 | ||
| Crucial role of NO and endothelium-derived hyperpolarizing factor in human sustained conduit artery flow-mediated dilatation | Q79317363 | ||
| Endothelin-1 regulates arterial pulse wave velocity in vivo | Q79353420 | ||
| Arterial wave reflections and determinants of endothelial function a hypothesis based on peripheral mode of action | Q79836516 | ||
| Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients | Q80020392 | ||
| At the beginning of stiffening: endothelial dysfunction meets "pulsology" | Q80184629 | ||
| Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans | Q80184638 | ||
| The role of endothelin-1 in vascular remodeling in vivo | Q83859486 | ||
| Prostacyclin and endothelium-dependent hyperpolarization | Q35693545 | ||
| Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients | Q35977921 | ||
| Endothelium-derived hyperpolarizing factor: a cousin to nitric oxide and prostacyclin | Q36138290 | ||
| Targeting endothelial dysfunction in hypertensive subjects | Q36216260 | ||
| Endothelium-derived epoxyeicosatrienoic acids and vascular function | Q36402109 | ||
| Homocysteine: role and implications in atherosclerosis | Q36410590 | ||
| Weight change is associated with change in arterial stiffness among healthy young adults | Q39593602 | ||
| Comparison of carotid intima-media thickness, arterial stiffness, and brachial artery flow mediated dilatation in diabetic and nondiabetic subjects (The Chennai Urban Population Study [CUPS-9]). | Q39632110 | ||
| Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium | Q40672044 | ||
| Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study. | Q40694210 | ||
| Prognostic significance of endothelial dysfunction in hypertensive patients | Q40697812 | ||
| Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study | Q40804261 | ||
| Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation | Q40884375 | ||
| Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro | Q42276791 | ||
| Gender-specific compensation for the lack of NO in the mediation of flow-induced arteriolar dilation | Q43610467 | ||
| Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension | Q43800759 | ||
| Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease | Q43808885 | ||
| Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient | Q43838577 | ||
| Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study | Q43859232 | ||
| Arterial stiffness and endothelial function in patients with beta-thalassemia major | Q44213380 | ||
| Effect of AT1 receptor blockade on endothelial function in essential hypertension | Q44297770 | ||
| Pulse pressure and endothelial dysfunction in never-treated hypertensive patients. | Q44454560 | ||
| Effects of coexisting hypertension and type II diabetes mellitus on arterial stiffness | Q44777691 | ||
| Non-invasively measured structural and functional arterial characteristics and coronary heart disease risk in middle aged and elderly men. | Q44845916 | ||
| The prostacyclin analogue beraprost sodium prevents development of arterial stiffness in elderly patients with cerebral infarction | Q44878695 | ||
| Nebivolol increases arterial distensibility in vivo. | Q44985645 | ||
| Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA. | Q45135207 | ||
| Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction | Q45159052 | ||
| Effect of hyperhomocysteinemia induced by methionine administration on flow-mediated dilatation of the brachial artery in healthy subjects | Q45238096 | ||
| Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure | Q46438911 | ||
| Basal NO locally modulates human iliac artery function in vivo. | Q46468920 | ||
| Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). | Q46695758 | ||
| Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production | Q47863878 | ||
| Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo | Q49137523 | ||
| Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes. | Q51471545 | ||
| Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice. | Q54083326 | ||
| Verapamil and nebivolol improve carotid artery distensibility in hypertensive patients. | Q54340034 | ||
| Role of Matrix Metalloproteinases in Blood Flow–Induced Arterial Enlargement | Q58150276 | ||
| eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis | Q64380479 | ||
| Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats | Q64382103 | ||
| Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus | Q71012849 | ||
| Endothelial Control of Arterial Distensibility Is Impaired in Chronic Heart Failure | Q71807619 | ||
| Do arterial endothelin 1 levels affect local arterial stiffness? | Q72541051 | ||
| Aortic pulse wave velocity index and mortality in end-stage renal disease | Q73215830 | ||
| Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease | Q73801210 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 269-275 | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | Current diabetes report | Q26841965 |
| P1476 | title | Arterial compliance and endothelial function | |
| P478 | volume | 7 |
| Q38237474 | Antioxidant vitamin supplementation reduces arterial stiffness in adults: a systematic review and meta-analysis of randomized controlled trials |
| Q44753291 | Association between arterial elasticity indices and coronary artery calcium in a healthy multi-ethnic cohort |
| Q35964757 | B-type natriuretic peptide is an independent predictor of endothelial function in man. |
| Q36980950 | Beyond type 2 diabetes, obesity and hypertension: an axis including sleep apnea, left ventricular hypertrophy, endothelial dysfunction, and aortic stiffness among Mexican Americans in Starr County, Texas |
| Q37735313 | Carotid femoral pulse wave velocity in type 2 diabetes and hypertension: capturing arterial health effects of step counts |
| Q59307077 | Central Adiposity and Protein Intake Are Associated with Arterial Stiffness in Overweight Children |
| Q34344072 | Effects of exercise modalities on arterial stiffness and wave reflection: a systematic review and meta-analysis of randomized controlled trials |
| Q55378837 | Endovascular stent-induced alterations in host artery mechanical environments and their roles in stent restenosis and late thrombosis. |
| Q61502176 | Lack of Correlation Between Cerebral Vasomotor Reactivity and Flow-Mediated Dilation in Subjects Without Vascular Disease |
| Q37798006 | Novel therapeutic strategies targeting vascular endothelium in essential hypertension |
| Q30667212 | Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study |
| Q91815913 | Sex Differences in Glutathione Peroxidase Activity and Central Obesity in Patients with Type 2 Diabetes at High Risk of Cardio-Renal Disease |
| Q33630821 | Sex differences in the combined effect of chronic stress with impaired vascular endothelium functioning and the development of early atherosclerosis: the Cardiovascular Risk in Young Finns study |
| Q37204282 | Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndrome |
| Q50567793 | Stress-induced cardiac autonomic reactivity and preclinical atherosclerosis: does arterial elasticity modify the association? |
Search more.